Current Trends and Future Perspectives in the Treatment of Pulmonary Arterial Hypertension

Sukhdeep Bhogal; Debabrata Mukherjee; Subhash Banerjee; Walter Tan; Timir K. Paul

doi:10.1016/j.cpcardiol.2017.10.002

Current Trends and Future Perspectives in the Treatment of Pulmonary Arterial Hypertension

Sukhdeep Bhogal, Debabrata Mukherjee, Subhash Banerjee, Walter Tan, Timir K. Paul

Research output: Contribution to journal › Article

Abstract

Pulmonary hypertension continues to be a life-threatening illness with debilitating physical and emotional consequences affecting around 1% of global population. The progression of this devastating disease is characterized by increase in pulmonary vascular resistance resulting in elevated pulmonary pressure, eventually leading to right heart failure and death. Better understanding of pathophysiology has led to substantial improvements in terms of availability of treatment options. The purpose of this review is to summarize the currently available treatment options along with pertinent trials and possible future therapies of pulmonary arterial hypertension.

Original language	English (US)
Pages (from-to)	191-216
Number of pages	26
Journal	Current Problems in Cardiology
Volume	43
Issue number	5
DOIs	https://doi.org/10.1016/j.cpcardiol.2017.10.002
State	Published - May 1 2018

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.cpcardiol.2017.10.002

Fingerprint Dive into the research topics of 'Current Trends and Future Perspectives in the Treatment of Pulmonary Arterial Hypertension'. Together they form a unique fingerprint.

Cite this

Bhogal, S., Mukherjee, D., Banerjee, S., Tan, W., & Paul, T. K. (2018). Current Trends and Future Perspectives in the Treatment of Pulmonary Arterial Hypertension. Current Problems in Cardiology, 43(5), 191-216. https://doi.org/10.1016/j.cpcardiol.2017.10.002

@article{afd4149711d14208aed1883ff002c605,

title = "Current Trends and Future Perspectives in the Treatment of Pulmonary Arterial Hypertension",

abstract = "Pulmonary hypertension continues to be a life-threatening illness with debilitating physical and emotional consequences affecting around 1% of global population. The progression of this devastating disease is characterized by increase in pulmonary vascular resistance resulting in elevated pulmonary pressure, eventually leading to right heart failure and death. Better understanding of pathophysiology has led to substantial improvements in terms of availability of treatment options. The purpose of this review is to summarize the currently available treatment options along with pertinent trials and possible future therapies of pulmonary arterial hypertension.",

author = "Sukhdeep Bhogal and Debabrata Mukherjee and Subhash Banerjee and Walter Tan and Paul, {Timir K.}",

year = "2018",

month = may,

day = "1",

doi = "10.1016/j.cpcardiol.2017.10.002",

language = "English (US)",

volume = "43",

pages = "191--216",

journal = "Current Problems in Cardiology",

issn = "0146-2806",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - Current Trends and Future Perspectives in the Treatment of Pulmonary Arterial Hypertension

AU - Bhogal, Sukhdeep

AU - Mukherjee, Debabrata

AU - Banerjee, Subhash

AU - Tan, Walter

AU - Paul, Timir K.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Pulmonary hypertension continues to be a life-threatening illness with debilitating physical and emotional consequences affecting around 1% of global population. The progression of this devastating disease is characterized by increase in pulmonary vascular resistance resulting in elevated pulmonary pressure, eventually leading to right heart failure and death. Better understanding of pathophysiology has led to substantial improvements in terms of availability of treatment options. The purpose of this review is to summarize the currently available treatment options along with pertinent trials and possible future therapies of pulmonary arterial hypertension.

AB - Pulmonary hypertension continues to be a life-threatening illness with debilitating physical and emotional consequences affecting around 1% of global population. The progression of this devastating disease is characterized by increase in pulmonary vascular resistance resulting in elevated pulmonary pressure, eventually leading to right heart failure and death. Better understanding of pathophysiology has led to substantial improvements in terms of availability of treatment options. The purpose of this review is to summarize the currently available treatment options along with pertinent trials and possible future therapies of pulmonary arterial hypertension.

UR - http://www.scopus.com/inward/record.url?scp=85034756887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034756887&partnerID=8YFLogxK

U2 - 10.1016/j.cpcardiol.2017.10.002

DO - 10.1016/j.cpcardiol.2017.10.002

M3 - Article

C2 - 29174585

AN - SCOPUS:85034756887

VL - 43

SP - 191

EP - 216

JO - Current Problems in Cardiology

JF - Current Problems in Cardiology

SN - 0146-2806

IS - 5

ER -